Prestige Diagnostics

Executive Summary

Prestige Diagnostics is a UK-based in vitro diagnostics (IVD) manufacturer and distributor specializing in high-quality reagents, assays, and point-of-care (POC) testing solutions, with a core focus on diabetes and HbA1c monitoring. Founded in 2012 and headquartered in London with operational facilities in Northern Ireland, the company leverages its unique position to serve both the UK and EU single markets seamlessly. By offering contract manufacturing and frictionless distribution across these regions, Prestige Diagnostics addresses the growing demand for decentralized diabetes management, capitalizing on the global rise in diabetes prevalence and the shift toward home-based and POC testing.

Upcoming Catalysts (preview)

• Q3 2026Launch of next-generation POC HbA1c analyzer70% success
• H2 2026EU IVDR certification for core product line60% success
• Q4 2026Strategic distribution partnership in continental Europe50% success